Shukra Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Shukra Pharmaceuticals has a total shareholder equity of ₹576.4M and total debt of ₹31.5M, which brings its debt-to-equity ratio to 5.5%. Its total assets and total liabilities are ₹778.4M and ₹202.0M respectively. Shukra Pharmaceuticals's EBIT is ₹207.2M making its interest coverage ratio 79.1. It has cash and short-term investments of ₹99.8M.
Key information
5.5%
Debt to equity ratio
₹31.54m
Debt
| Interest coverage ratio | 79.1x |
| Cash | ₹99.80m |
| Equity | ₹576.40m |
| Total liabilities | ₹201.98m |
| Total assets | ₹778.37m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524632's short term assets (₹562.3M) exceed its short term liabilities (₹141.5M).
Long Term Liabilities: 524632's short term assets (₹562.3M) exceed its long term liabilities (₹60.4M).
Debt to Equity History and Analysis
Debt Level: 524632 has more cash than its total debt.
Reducing Debt: 524632's debt to equity ratio has reduced from 41.1% to 5.5% over the past 5 years.
Debt Coverage: 524632's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 524632's interest payments on its debt are well covered by EBIT (79.1x coverage).